Menu Search
Equities

Redsense Medical AB (publ)

R0Z:FRA

Redsense Medical AB (publ)

Actions
  • Price (EUR)0.542
  • Today's Change0.006 / 1.12%
  • Shares traded0.00
  • 1 Year change-24.51%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 14:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Redsense Medical AB (publ) grew revenues 74.11% from 14.34m to 24.97m while net income improved from a loss of 8.76m to a smaller loss of 4.51m.
Gross margin20.47%
Net profit margin-16.72%
Operating margin-16.54%
Return on assets-12.58%
Return on equity-14.51%
Return on investment-14.51%
More ▼

Cash flow in SEKView more

In 2023, Redsense Medical AB (publ) increased its cash reserves by 89.71%, or 3.29m. Cash Flow from Investing totalled 8.35m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.05m for operations while cash from financing was breakeven.
Cash flow per share-0.2717
Price/Cash flow per share--
Book value per share1.95
Tangible book value per share1.08
More ▼

Balance sheet in SEKView more

Redsense Medical AB (publ) has little financial risk as the capital structure does not rely on leverage.
Current ratio4.86
Quick ratio4.00
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.